Shin-Etsu Chemical Co Ltd Unsponsored ADR AI Stock Analysis
Want to see SHECY full AI Analyst Report?
Shin-Etsu Chemical Co Ltd Unsponsored ADR (SHECY) AI Stock Analysis
Shin-Etsu Chemical Co Ltd Unsponsored ADR
(Other OTC:SHECY)
The score is driven primarily by strong financial quality—especially the conservatively financed balance sheet and solid profitability/cash generation—partly offset by margin normalization and only moderate free-cash-flow conversion. Technical indicators are largely neutral with a weak longer-term trend, and valuation is moderate given the P/E of 23.3 and ~2.0% dividend yield.
Shin-Etsu Chemical Co Ltd Unsponsored ADR (SHECY) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $69.57B
- Dividend Yield
- 2.07%
- Average Volume (3M)
- 485.20K
- Price to Earnings (P/E)
- 21.7
- Beta (1Y)
- 1.11
- Revenue Growth
- -0.47%
- EPS Growth
- -0.52%
- Country
- US
- Employees
- 27,342
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals
Shin-Etsu Chemical Co Ltd Unsponsored ADR Business Overview & Revenue Model
Company Description
Shin-Etsu Chemical Co., Ltd. engages in the manufacture and sale of industrial chemicals. Its operations are carried out through the following segments: Living Environment Basic Materials Business, Electronic Materials Business, Functional Materials...
How the Company Makes Money
Shin-Etsu makes money by manufacturing and selling chemical and materials products to industrial customers worldwide, generating revenue primarily from product sales across several major business lines. A key earnings driver is its semiconductor mate...
Shin-Etsu Chemical Co Ltd Unsponsored ADR Financial Statement Overview
Summary
Strong overall fundamentals supported by very low leverage (debt-to-equity ~0.06) and solid profitability (TTM gross margin 33.9%, net margin 18.4%). Cash generation is healthy with operating cash flow exceeding net income (~1.45x) and positive free cash flow with strong TTM growth (+21.5%), but margin normalization from 2022–2023 highs and only moderate free cash flow conversion (~0.51x of net income) temper the score.
Income Statement
78PositiveBalance Sheet
92Very PositiveCash Flow
74Positive| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.59T | 2.56T | 2.73T | 2.41T | 2.81T | 2.07T |
| Gross Profit | 924.89B | 984.12B | 933.91B | 911.21B | 1.21T | 868.00B |
| EBITDA | 946.67B | 980.46B | 931.14B | 1.02T | 1.24T | 865.91B |
| Net Income | 500.04B | 534.02B | 503.07B | 520.14B | 708.24B | 500.12B |
Balance Sheet | ||||||
| Total Assets | 5.36T | 5.64T | 5.69T | 5.15T | 4.73T | 4.05T |
| Cash, Cash Equivalents and Short-Term Investments | 1.54T | 1.81T | 1.67T | 1.72T | 1.60T | 1.44T |
| Total Debt | 243.91B | 16.84B | 244.35B | 24.30B | 29.81B | 30.40B |
| Total Liabilities | 975.29B | 799.02B | 1.02T | 723.90B | 704.19B | 624.21B |
| Stockholders Equity | 4.22T | 4.66T | 4.48T | 4.26T | 3.87T | 3.33T |
Cash Flow | ||||||
| Free Cash Flow | 385.34B | 439.10B | 380.68B | 377.70B | 488.65B | 355.97B |
| Operating Cash Flow | 785.18B | 881.93B | 755.63B | 755.18B | 788.01B | 553.53B |
| Investing Cash Flow | -213.94B | -142.55B | -577.66B | -1.10T | -186.49B | -253.72B |
| Financing Cash Flow | -526.64B | -454.90B | -535.28B | -369.47B | -423.56B | -122.50B |
Shin-Etsu Chemical Co Ltd Unsponsored ADR Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SHECY, the sentiment is Negative. The current price of 17.86 is below the 20-day moving average (MA) of 18.41, below the 50-day MA of 18.68, and below the 200-day MA of 20.10, indicating a bearish trend. The MACD of -0.34 indicates Positive momentum. The RSI at 42.56 is Neutral, neither overbought nor oversold. The STOCH value of 38.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SHECY.
Shin-Etsu Chemical Co Ltd Unsponsored ADR Peers Comparison
Overall Rating
WLKP84Outperform
SHECY70Outperform
CE61Neutral
DOW60Neutral
DD55Neutral
BAK39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 84Outperform | $753.36M | 12.83 | 15.70% | 8.80% | 9.40% | 20.34% | |
| 70Outperform | $69.89B | 21.72 | 11.28% | 2.07% | -0.47% | -0.52% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 61Neutral | $5.37B | 21.62 | 6.35% | 0.23% | 1.43% | ― | |
| 60Neutral | $22.79B | -25.82 | -4.50% | 4.30% | 4.16% | 20.86% | |
| 55Neutral | $20.79B | 69.16 | 2.18% | 1.54% | -43.45% | ― | |
| 39Underperform | $443.70M | -0.50 | 46.16% | ― | -1.40% | 2.39% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SHECY | Shin-Etsu Chemical Co Ltd Unsponsored ADR | 17.86 | 2.91 | 19.45% | |
| CE | Celanese | 51.45 | 12.60 | 32.44% | |
| BAK | Braskem Sa | 1.10 | -1.95 | -63.93% | |
| WLKP | Westlake Chemical Partners LP | 21.42 | 4.03 | 23.15% | |
| DD | DuPont de Nemours, Inc. | 155.61 | 38.54 | 32.92% | |
| DOW | Dow Inc. | 32.54 | 10.69 | 48.92% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 29, 2026
